- Glioma Diagnosis and Treatment
- Meningioma and schwannoma management
- Cerebrospinal fluid and hydrocephalus
- Traumatic Brain Injury and Neurovascular Disturbances
- Vascular Malformations Diagnosis and Treatment
- Brain Metastases and Treatment
- Intracranial Aneurysms: Treatment and Complications
- Neurofibromatosis and Schwannoma Cases
- Pituitary Gland Disorders and Treatments
- Spine and Intervertebral Disc Pathology
- Spinal Dysraphism and Malformations
- CAR-T cell therapy research
- Radiomics and Machine Learning in Medical Imaging
- Neuroblastoma Research and Treatments
- Diversity and Career in Medicine
- Head and Neck Surgical Oncology
- Spinal Fractures and Fixation Techniques
- Neurosurgical Procedures and Complications
- Anesthesia and Pain Management
- Global Health and Surgery
- Epilepsy research and treatment
- Surgical Simulation and Training
- Nanoplatforms for cancer theranostics
- Cerebrovascular and Carotid Artery Diseases
- Histone Deacetylase Inhibitors Research
University of Miami
2020-2025
Neurological Surgery
2020-2025
Jackson Health System
2020-2025
Jackson Memorial Hospital
2022-2025
Miami Children's Hospital
2020-2025
Sylvester Comprehensive Cancer Center
2021-2025
Hospital del Niño
2024
Ministerio de Salud
2024
Miami University
2024
Tandem Diabetes Care (United States)
2024
Monitor and wand-based neuronavigation stations (MWBNSs) for frameless intraoperative are routinely used in cranial neurosurgery. However, they temporally spatially cumbersome; the OR must be arranged around MWBNS, at least one hand to manipulate MWBNS wand (interrupting a bimanual surgical technique), workflow is interrupted as surgeon stops "check navigation" on remote monitor. Thus, there need continuous, real-time, hands-free, solutions. Augmented reality (AR) poised streamline these...
BACKGROUND: Vestibular schwannomas (VSs) related to neurofibromatosis type 2 (NF2) are challenging tumors. The increasing use of stereotactic radiosurgery (SRS) necessitates further investigations its role and safety. OBJECTIVE: To evaluate tumor control, freedom from additional treatment (FFAT), serviceable hearing preservation, radiation-related risks patients with NF2 after SRS for VS. METHODS: We performed a retrospective study 267 (328 VSs) who underwent single-session at 12 centers...